Kelly S. Kraft

Improved Bioavailability with Dry Powder Cannabidiol Inhalation: A Phase 1 Clinical Study

Orrin Devinsky, Kelly S. Kraft, Lorraine M. Rusch et al. · Journal of Pharmaceutical Sciences · 2021 · 50 citations · Full text

Pharmacotherapy, Cannabinoid Pharmacology, Translational Pharmacology +18

A Delineation of Diketopiperazine Self-Assembly Processes: Understanding the Molecular Events Involved in <i>N</i>^ϵ-(Fumaroyl)diketopiperazine of <scp>l</scp>-Lys (FDKP) Interactions

Navneet Kaur, Bo Zhou, Fred W. Breitbeil et al. · Molecular Pharmaceutics · 2008 · 31 citations

Carboxylic Acid Analogues of Tamoxifen:  (<i>Z</i>)-2-[<i>p</i>-(1,2-Diphenyl-1-butenyl)phenoxy]-<i>N,N</i>-dimethylethylamine. Estrogen Receptor Affinity and Estrogen Antagonist Effects in MCF-7 Cells

Kelly S. Kraft, Peter C. Ruenitz, Michael G. Bartlett · Journal of Medicinal Chemistry · 1999 · 17 citations · Full text

Hormonal Contraceptive, Estrogen Receptor Affinity, Estrogen Receptor +18

Heat-Stable Dry Powder Oxytocin Formulations for Delivery by Oral Inhalation

Karine Fabio, Kieran Curley, J.J. Guarneri et al. · AAPS PharmSciTech · 2015 · 16 citations · Full text

Oral Inhalation, Medicine, Drug Delivery System +3

Preparation of Macromolecule-Containing Dry Powders for Pulmonary Delivery

Kelly S. Kraft, Marshall Grant · Methods in molecular biology · 2008 · 11 citations